TMBR

Timber Pharmaceuticals, Inc.
TMBR

Overview Fund Activity
Delisted

TMBR was delisted on the 28th of November, 2023.

Back to rankings

20 hedge funds and large institutions have $3.19M invested in Timber Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$683K
2
Renaissance Technologies
Renaissance Technologies
New York
$59K
3
Deutsche Bank
Deutsche Bank
Germany
$59K
4
TSS
Two Sigma Securities
New York
$21K
5
LFAS
Level Four Advisory Services
Texas
$7K

Top Sellers

1
Franklin Resources
Franklin Resources
California
$494K
2
Barclays
Barclays
United Kingdom
$0
3
Citadel Advisors
Citadel Advisors
Florida
$0
4
Millennium Management
Millennium Management
New York
$3K
5
Goldman Sachs
Goldman Sachs
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ADL
26
Asset Dedication LLC
California
– -$1K – –
1
2